Atlas Trials

Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions

Clinical trial NCT00407355 · COMPLETED

Trial details

NCT number
NCT00407355
Sponsor
Peter A Campochiaro, MD
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Macular EdemaRetinal Vein Occlusion
Start date
2006-01-01
Primary completion
2013-02-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.